CITIUS ONCOLOGY, INC. (CTOR): Nasdaq/NYSE listing notice — Citius Oncology receives Nasdaq deficiency notice for falling below $1.00 bid price

CITIUS ONCOLOGY, INC.

Nasdaq notified Citius Oncology on April 22, 2026 that bid price closed below $1.00 for 30 consecutive business days.
Company has 180 days, until October 19, 2026, to regain compliance by closing at $1.00+ for 10 consecutive days.
If not compliant, may get additional 180 days if meet other standards and intend to cure via reverse stock split.
Company is evaluating options; stock continues trading under symbol CTOR.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

CITIUS ONCOLOGY, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

April 22, 2026, Nasdaq Stock Market LLC (“Nasdaq”) notified Citius Oncology, Inc. (the “Company”) that for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

CITIUS ONCOLOGY, INC. filing history →

Source: SEC EDGAR

accession 0001213900-26-048629

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.